Therapeutics: non-bacterial infection

Buy now to access the full article, existing subscribers login

Non-bacterial infections

Antifungal agents

Topical agents
  • Treatment of fungal infections of skin, ear and eye.
Skin infections
  • Successful treatment depends on management which limits infection, eg grooming, clipping, isolation, cleansing agents for animal and environment.
  • Systemic agents may be used also.
Dermatophytoses:
  • Infections Skin: dermatophytosis commonly caused by Trichophyton spp Trichophyton spp , and Microsporum Microsporum canis :
    • Enilconazole Enilconazole wash.

Pruritic skin disease

  • Seborrhea Skin: primary seborrhea and otitis externa Skin: otitis externa caused by Malassezia pachydermatis:
    • Enilconazole Enilconazole wash.
    • Ketoconazole * Ketoconazole shampoo.

Others

  • Povidone-iodine Povidone-iodine solution.

Ear infections

  • Usually combination preparations.

Yeasts

  • Nystatin * Nystatin.
  • Miconazole * Miconazole.

Eye infections

  • Conditions may be superficial, eg mycotic keratitis Keratitis or intra-ocular, eg mycotic endophthalmitis Endophthalmitis/Panophthalmitis.
  • Most topical preparations have poor corneal penetration, so systemic preparations preferred.

Aspergillosis

  • For nasal infection Aspergillosis: disseminated with Aspergillus fumigatus Aspergillus fumigatus : combination treatment with systemic ketoconazole *, surgery and intrasinus treatment using enilconazole * Enilconazole.
  • May also treat with intranasally instilled clotrimazole Clotrimazole.

Systemic agents

  • Griseofulvin Griseofulvin.
  • For dermatophyte infections.
  • Deposited in keratin precursor cells → stratum corneum of skin, hair and nails → prevents fungal invasion of new cells.
  • Absorption enhanced by administration with fatty meal.
  • Treatment usually minimum 3-4 weeks → 12 weeks.
    May be teratogenic: avoid handling by pregnant women

Imidazoles

  • Interfere with biosynthesis of ergosterol.
  • Fungistatic.
  • Broad spectrum.
  • Clotrimazole Clotrimazole.
  • Topical.
  • Malassezia infection Skin: malassezia disease (as 1% solution).
  • Miconazole Miconazole.
  • Topical.
  • Too toxic for treatment of systemic fungal infections.
  • Ketoconazole * Ketoconazole.
  • Active against fungi and yeasts, some gram-positive bacteria.
  • For systemic candidiasis and refractory dermatophytoses.
  • Administration with food may → nausea. Do not administer with antacids, which can reduce its absorption.
  • Interferes with mammalian adrenal and gonadal steroid synthesis → alternative treatment for Cushing's disease (hyperadrenocorticism Hyperadrenocorticism ).

    May be teratogenic; prolonged administration may result in liver damage
  • Itraconazole * Itraconazole.
  • Systemic candidiasis, refractory dermatophytoses, sytemic fungal infections.

    Do not administer with antacids, which can reduce its absorption.
  • Fluconazole Fluconazole.
  • Systemic candidiasis, refractory dermatophytosis, systemic fungal infections.
  • Absorption not affected by antacids.
  • Nystatin * Nystatin.
  • Gastrointestinal candidiasis Candida albicans.
  • Amphotericin * Amphotericin B.
  • Against yeasts and fungi. Used for life-threatening or refractory systemic fungal infections.
  • Nephrotoxic. Requires saline diuresis. Liposomal formulation markedly reduces nephrotoxicity.

Antiviral agents

  • Used mainly in ophthalmology.

Eye infections

  • Feline herpesvirus - conjunctivitis Conjunctivitis and keratitis Keratitis.
  • Aciclovir * Acyclovir.

Antiprotozoal agents

Coccidiosis

  • Isospora spp Isospora canis infections.
  • Co-trimazine (trimethoprim + sulfadiazine) Trimethoprim.

Neosporosis

  • Neospora caninum Neospora caninum.
  • Clindamycin Clindamycin.
  • Co-trimazine (trimethoprim + sulfadiazine) - see above, also in combination with pyrimethamine.

Toxoplasmosis

  • Clindamycin Clindamycin.
  • Co-trimazine (trimethoprim + sulfaziazine) - see above, also in combination with pyrimethamine.

Giardiasis

  • Giardia spp Giardia spp.
  • Metronidazole Metronidazole.
  • Fenbendazole Fenbendazole.
  • * Indicates not licensed for this use in this species.

Sources

Publications

Refereed papers


  • Recent references from PubMed.

Other sources of information

  • Lappin M R (2000) Protozoal and miscellaneous infections. In: Textbook of Veterinary Internal Medicine.5th edn. Ettinger S J & Feldman E C (eds). W B Saunders, Philadelphia. pp 408-417.
  • Taboada J (2000) Systemic mycoses. In: Textbook of Veterinary Internal Medicine.5th edn. Ettinger S J & Feldman E C (eds). W B Saunders, Philadelphia. pp 453-476.
  • Plumb D C (1999) Veterinary Drug Handbook. 3rd edn. Iowa State University Press, Ames, Iowa.

Sample content only, to unlock the full article login or buy now

Loading...